Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT07484217

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

CLARITY (Clinical Assessment of Response in the Treatment of Depression with Daytime Sleepiness Using Solriamfetol) is a Phase 3, double-blind, placebo-controll…

United States508 participantsStarted 2026-02-23Updated 2026-07-24

Treatment: Solriamfetol 150 MG, Placebo

All recent trials (2 shown)

CompletedPhase 2

NCT00385437

Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder

This concurrent, two-part study will: I) Using overnight sleep recordings, evaluate the short- and long-term sleep-promoting effects of the antidepressant mirt…

Canada16 participantsStarted 2003-04Updated 2006-10-09

Treatment: Driving Simulator Testing, Mirtazapine Treatment